Cristália Produtos Químicos Farmacêuticos Ltda.

This early-stage trial tests the safety of a drug called CRIS100 in 5 adults with a recent spinal cord injury in the middle-to-lower back. Participants receive a single dose injected into the injury site within 72 hours of the accident. The study monitors side effects and checks …

This early-stage study tests a new liposome formula designed to rescue people from drug overdoses. It involves 12 healthy adults aged 18 to 30 to check for side effects and how the body processes the drug. The goal is to gather safety information, not to treat any disease.